Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13784275 | 0.85 | TERT (0.35) | ESR1ESR2 | |
| SCHEMBL13784274 | 0.83 | APAF1 (0.34) | ESR1ESR2 | |
| SCHEMBL1455596 | 0.81 | CA9 (0.33) | GRM1 | |
| SCHEMBL12347165 | 0.79 | POLB (0.45) | ESR1ESR2 | |
| SCHEMBL13577705 | 0.79 | POLB (0.39) | ESR1ESR2GRM1 | |
| SCHEMBL13578749 | 0.75 | GRM1 (0.33) | GRM1 | |
| SCHEMBL12347156 | 0.74 | POLB (0.41) | ESR1ESR2 | |
| SCHEMBL13466787 | 0.74 | ANPEP (0.56) | — | |
| SCHEMBL9966943 | 0.74 | ALDH1A1 (0.38) | — | |
| SCHEMBL2222018 | 0.73 | TERT (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350035-B2 | Fluorinated rylenetetracarboxylic acid derivatives and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-01-08 | — | — | US | disclosed |
| US-8350035-B2 | Fluorinated rylenetetracarboxylic acid derivatives and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-01-08 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| WO-2007093643-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | ESR1 1462/4885ESR2 1343/4885GRM1 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.